Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🇿🇦 ZA Market
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Healthcare
Any
Automobiles
Banks
Capital Goods
Commercial Services
Consumer Durables
Consumer Services
Diversified Financials
Energy
Consumer Retailing
Food, Beverage & Tobacco
Healthcare
Household
Insurance
Materials
Media
Pharmaceuticals & Biotech
Real Estate
Retail
Semiconductors
Software
Tech
Telecom
Transportation
Utilities
Create a narrative
Community
/
South Africa
/
Healthcare
Healthcare South African Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Healthcare South African Investing Ideas
All companies
Popular
Undervalued
Overvalued
Life Healthcare Group Holdings
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging Population And Digital Health Will Redefine Healthcare
Key Takeaways Accelerating hospital expansion and digital health investments are set to drive sustained growth and open new high-margin revenue streams. Strong balance sheet and efficient capital management enable aggressive geographic expansion and high returns compared to competitors.
View narrative
R18.60
FV
27.3% undervalued
intrinsic discount
4.02%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Life Healthcare Group Holdings
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Rising Regulatory Burdens And Costs Will Shrink South African Demand
Key Takeaways Long-term revenue growth is threatened by shifts to outpatient care, rising labor costs, and regulatory pressures constraining pricing power and margins. Structural economic and affordability barriers, along with high fixed costs, may limit patient volumes and dampen returns on investment.
View narrative
R12.30
FV
10.0% overvalued
intrinsic discount
2.33%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Life Healthcare Group Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expanding NeuraCeq Sales And Southern Africa Hospitals Will Improve Future Market Position
Key Takeaways Expansion in Southern Africa and investments in high-margin imaging services are expected to significantly boost revenue and future earnings. An under-leveraged balance sheet positions the company well to fund growth opportunities, enhancing return on equity.
View narrative
R15.44
FV
12.4% undervalued
intrinsic discount
2.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
3 days ago
author updated this narrative
Netcare
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Data Analytics Platform Will Optimize Clinical Operations By End Of 2024
Key Takeaways Digitization and data-driven strategies optimize operations, reduce costs, and enhance net margins and competitive positioning through improved clinical efficiency. Environmental and product expansion strategies aim for sustainable growth, yielding new revenue streams and positive stakeholder perception.
View narrative
R16.42
FV
15.2% undervalued
intrinsic discount
5.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
3 months ago
author updated this narrative
Value any company in seconds
Popular companies